CO [Chinard Bloodrp] 20-F: TABLE OFNTENTS PART I 4 ITEM 1. IDENTITY

[TABLE OFNTENTS PART I 4 ITEM 1. IDENTITY OF DIRECTORS, SENIOR MANAGEMENT ANDVISERS 4 ITEM 2. OFFER STATISTICS AND EXPECTED TIMETABLE 4 ITEM 3. KEY INFORMATION 4 A. Selected financialta 4 B.pitalization and Indebtedness 6 C. Reasons for the Offer and Use of Proceeds 7 D. Risk factors] [Guangzhou City Real Estate Property Purchasereement Seller (Party A):Guangzhou Hezhong CD Manufacturing Legal Representative:ZHU Suifeng Buyer (Party B):Guangzhou Municipality Tianhe Nuoya Bio-engineering Legal Representative:ZHENG Ting Article IParty A desires to transfer the real estate property it owns,luding the land use right to the surrounding public green area and road (See Property Layout Plan attached for] [Hundsun (Hangzhou)ience & Technology Park Property Transferreementntract #: H216 ( Party A (Transferor): Hangzhou Hundsun Baichuan Technology Legal Representative: HU Weiguo Party B (Transferee): Beijing Jiachenhong Biological Technologies Legal Representative: DENG Yue Article IBackground of thenstruction Project Party A entered into anreement Statenstruction Land Use Right Transferntract (contract No. 3301102009A21063) with Hangzhou Municipal Bureau of] [List of Subsidiaries Name Jurisdiction Chinard Blood Servicesrporationyman Islands China Stem Cellss Limitedyman Islands Beijing Jiachenhong Biological Technologies Peoples Republic of China Guangzhou Municipality Tianhe Nuoya Bio-engineering Peoples Republic of China Zhejiang Lukou Biotechnology Peoples Republic of China China Stem Cells (East)mpany Limited] [Certification I, Ting Zheng, certify that: 1. I have reviewed this annual report on Form 20-F of Chinard Bloodrporation; 2. Based on my knowledge, this report does notntain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which] [Certification I,bert Chen, certify that: 1. I have reviewed this annual report on Form 20-F of Chinard Bloodrporation; 2. Based on my knowledge, this report does notntain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such] [Certification CHINARD BLOODRPORATION July 31, 2013 Ting Zheng Chief Executive Officer July 31, 2013bert Chen Chief Financial Officer (Principal Financial and Accounting Officer) v349858_ex13-1.htm 7 EX-13.1] [CONSENT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM The Board of Directors Chinard Bloodrporation: Hong Kong, China July 31, 2013 v349858_ex15-1.htm 8 EX-15.1]

By | 2016-02-04T15:54:30+00:00 July 31st, 2013|Categories: Chinese Stocks, CO, Webplus ver|Tags: , , , , , |0 Comments

CO [Chinard Bloodrp] SC 13D/A: CUSIP No. G21107 100 13D/A Page 2 of

[CUSIP No. G21107 100 13D/A Page 2 of 5 Pages 1 NAME OF REPORTING PERSONS GOLDEN MEDITECH STEM CELLS (BVI)MPANY LIMITED 2 CHECK THE APPROPRIATE BOX IF A MEMBER OF A (a) o o 3 SEC USE ONLY 4 SOURCE OF FUNDS* OO, BK 5 6 CITIZENSHIP OR PLACE OF ORGANIZATION]

By | 2016-02-04T15:55:55+00:00 July 11th, 2013|Categories: Chinese Stocks, CO, Webplus ver|Tags: , , , , , |0 Comments

CO [China Cord Blood] CORRESP: (Original Filing)

[June 27, 2013 Tia L. Jenkins Re: China Cord Blood Corporation Form 20-F for Fiscal Year ended March 31, 2012 Filed July 31, 2012 Response Dated May 21, 2013 File No. 001-34541 Dear Ms. Jenkins: We hereby provide responses to comments issued on June 14, 2013 (the “Staff’s Letter”) regarding the Annual Report on Form 20-F of China Cord Blood]

By | 2016-02-29T13:28:50+00:00 June 27th, 2013|Categories: Chinese Stocks, CO, SEC Original|Tags: , , , , , |0 Comments
Skip to toolbar